Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YNL128W | TEP1 | SGDID:S000005072 | DUSP4 MKP2 VH2 |
Dual specificity protein phosphatase 4 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH2) (Mitogen-activated protein kinase phosphatase 2) (MAP kinase phosphatase 2) (MKP-2) |
3.1.3.16,3.1.3.48, | Homo sapiens | Ogden Syndrome |
3ezz_b | Q13115 | ENSG00000120875 | DUSP4 | 98.00 | 2.70E-09 | 3.00E-13 | 84.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | Tk-ptp TK0241 |
Tk-ptp TK0241 |
Thermococcus kodakarensis | 5z59_a | Q8X270 | 98.50 | 3.50E-11 | 3.70E-15 | 97.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL128W | TEP1 | SGDID:S000005072 | PTP4A3 PRL3 |
Protein tyrosine phosphatase type IVA 3 (EC 3.1.3.48) (PRL-R) (Protein-tyrosine phosphatase 4a3) (Protein-tyrosine phosphatase of regenerating liver 3) (PRL-3) |
3.1.3.48 | Homo sapiens | Ocular Melanoma,Functioning Pituitary Adenoma,Colorectal Cancer,Pharynx Squamous Cell Carcinoma,Melanoma, Uveal |
1r6h_a | O75365 | ENSG00000184489 | PTP4A3 | 98.30 | 1.20E-10 | 1.20E-14 | 97.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | PRL-1 LMJF_16_0230 |
Protein tyrosine phosphatase PRL-1 (EC 3.1.3.48) |
3.1.3.48 | Leishmania major | 3s4o_a | Q4QEZ7 | 98.20 | 2.70E-10 | 2.70E-14 | 95.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | DUSP10 MKP5 |
Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 5) (MAP kinase phosphatase 5) (MKP-5) |
3.1.3.16,3.1.3.48, | Homo sapiens | Shwartzman Phenomenon |
1zzw_a | Q9Y6W6 | ENSG00000143507 | DUSP10 | 98.10 | 1.10E-09 | 1.20E-13 | 87.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | CDC14 OAF3 YFR028C |
Tyrosine-protein phosphatase CDC14 (EC 3.1.3.48) |
3.1.3.48 | Saccharomyces cerevisiae | 6g84_b | Q00684 | 98.60 | 6.00E-12 | 5.70E-16 | 123.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | DUSP19 DUSP17 LMWDSP3 SKRP1 |
Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase TS-DSP1) (Low molecular weight dual specificity phosphatase 3) (LMW-DSP3) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1) (SAPK pathway-regulating phosphatase 1) |
3.1.3.16,3.1.3.48, | Homo sapiens | 4d3p_a | Q8WTR2 | ENSG00000162999 | DUSP19 | 98.20 | 5.70E-10 | 6.20E-14 | 89.90 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL128W | TEP1 | SGDID:S000005072 | RNGTT CAP1A |
mRNA-capping enzyme (HCAP1) (HCE) [Includes: Polynucleotide 5'-triphosphatase (EC 3.1.3.33) (mRNA 5'-triphosphatase) (TPase); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)] |
2.7.7.50,3.1.3.33, | Homo sapiens | Photokeratitis,Blepharochalasis |
2c46_b | O60942 | ENSG00000111880 | RNGTT | 98.30 | 2.40E-10 | 2.30E-14 | 104.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | DNAJC6 |
Putative tyrosine-protein phosphatase auxilin (EC 3.1.3.48) (DnaJ homolog subfamily C member 6) |
3.1.3.48 | Bos taurus | 3n0a_a | Q27974 | 99.40 | 4.40E-17 | 4.20E-21 | 159.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | DUSP22 JSP1 LMWDSP2 MKPX |
Dual specificity protein phosphatase 22 (EC 3.1.3.16) (EC 3.1.3.48) (JNK-stimulatory phosphatase-1) (JSP-1) (Low molecular weight dual specificity phosphatase 2) (LMW-DSP2) (Mitogen-activated protein kinase phosphatase x) (MAP kinase phosphatase x) (MKP-x) |
3.1.3.16,3.1.3.48, | Homo sapiens | Breast Implant-Associated Anaplastic Large Cell Lymphoma,Duane Retraction Syndrome,Anterior Segment Dysgenesis 3,Sezary'S Disease,Alk-Negative Anaplastic Large Cell Lymphoma,Variola Major,Mature T-Cell And Nk-Cell Lymphoma,Anaplastic Large Cell Lymphoma,Peripheral T-Cell Lymphoma |
4woh_a | Q9NRW4 | ENSG00000112679 | DUSP22 | 98.00 | 1.70E-09 | 1.70E-13 | 90.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | SIW14 OCA3 YNL032W N2746 |
Inositol phosphatase SIW14 (EC 3.6.1.52) (5-PP-InsP phosphatase) (Inositol pyrophosphate phosphatase SIW14) (Oxidant-induced cell-cycle arrest protein 3) (Synthetic interaction with WHI2 protein 14) |
3.6.1.52 | Saccharomyces cerevisiae | 6byf_b | P53965 | 98.00 | 3.00E-09 | 3.10E-13 | 89.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | SSH2 KIAA1725 SSH2L |
Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L) |
3.1.3.16,3.1.3.48, | Homo sapiens | Familial Renal Oncocytoma |
2nt2_a | Q76I76 | ENSG00000141298 | SSH2 | 98.20 | 4.30E-10 | 4.60E-14 | 89.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | Rngtt Cap1a |
mRNA-capping enzyme (HCE) (MCE1) [Includes: Polynucleotide 5'-triphosphatase (TPase) (mRNA 5'-triphosphatase) (EC 3.1.3.33); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)] |
2.7.7.50,3.1.3.33, | Mus musculus | 1i9t_a | O55236 | 98.30 | 2.50E-10 | 2.50E-14 | 101.00 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | DUSP5 VH3 |
Dual specificity protein phosphatase 5 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH3) |
3.1.3.16,3.1.3.48, | Homo sapiens | Diamond-Blackfan Anemia 4,Schuurs-Hoeijmakers Syndrome,Syphilitic Meningitis,Lymphoma, Mucosa-Associated Lymphoid Type,Autosomal Dominant Non-Syndromic Intellectual Disability |
2g6z_a | Q16690 | ENSG00000138166 | DUSP5 | 98.30 | 1.50E-10 | 1.50E-14 | 103.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | DUSP16 KIAA1700 MKP7 |
Dual specificity protein phosphatase 16 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 7) (MAP kinase phosphatase 7) (MKP-7) |
3.1.3.16,3.1.3.48, | Homo sapiens | Obstructive Hydrocephalus |
4yr8_d | Q9BY84 | ENSG00000111266 | DUSP16 | 98.00 | 2.60E-09 | 2.70E-13 | 89.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | PTP ORF1 |
Tyrosine-protein phosphatase (EC 3.1.3.48) (BVP) |
3.1.3.48 | Autographa californica | 1yn9_b | P24656 | 98.40 | 5.80E-11 | 6.10E-15 | 99.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | DUSP29 DUPD1 DUSP27 |
Dual specificity phosphatase 29 (Dual specificity phosphatase 27) (Dual specificity phosphatase DUPD1) (EC 3.1.3.16) (EC 3.1.3.48) |
3.1.3.16,3.1.3.48, | Homo sapiens | Clubfoot,Familial Clubfoot With Or Without Associated Lower Limb Anomalies,Kat6b-Related Multiple Congenital Anomalies Syndrome,Cryptorchidism, Unilateral Or Bilateral,Kat6b Disorders,Cervix Carcinoma,Blepharophimosis,Lin-Gettig Syndrome,Ohdo Syndrome, Say-Barber-Biesecker-Young-Simpson Variant,Alacrima, Achalasia, And Mental Retardation Syndrome,Clubfoot, Congenital, With Or Without Deficiency Of Long Bones And/Or Mirror-Image Polydactyly,Disease Of Mental Health,Ohdo Syndrome, Sbbys Variant,Variola Major,Genitopatellar Syndrome,Hypertelorism,Ohdo Syndrome |
2y96_a | Q68J44 | ENSG00000188716 | DUPD1 | 98.40 | 7.30E-11 | 7.30E-15 | 105.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | EHI_044170 |
EHI_044170 |
3.1.3.- | Entamoeba histolytica | 3emu_a | D0VX03 | 98.00 | 2.40E-09 | 2.50E-13 | 88.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | DUSP8 C11orf81 VH5 |
Dual specificity protein phosphatase 8 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH-5) |
3.1.3.16,3.1.3.48, | Homo sapiens | 4jmk_a | Q13202 | ENSG00000184545 | DUSP8 | 98.20 | 5.50E-10 | 5.90E-14 | 90.70 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL128W | TEP1 | SGDID:S000005072 | PTP4A1 PRL1 PTPCAAX1 |
Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (PTP(CAAXI)) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1) |
3.1.3.48 | Homo sapiens | Ovarian Lymphoma,Bronchus Cancer,Breast Cancer,Colorectal Cancer |
1rxd_b | Q93096 | ENSG00000112245 | PTP4A1 | 98.30 | 1.50E-10 | 1.50E-14 | 95.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | EPM2A |
Laforin (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase) (LAFPTPase) |
3.1.3.16,3.1.3.48, | Homo sapiens | Progressive Myoclonus Epilepsy,Chromosome 1q21.1 Duplication Syndrome,Epilepsy,Myoclonus Epilepsy,Endocervical Carcinoma,Progressive Myoclonus Epilepsy 10,Progressive Myoclonus Epilepsy 6,Dementia,Progressive Myoclonus Epilepsy, Lafora Type,Early Myoclonic Encephalopathy,Myoclonus,Benign Epilepsy With Centrotemporal Spikes,Unverricht-Lundborg Syndrome,Dentatorubral-Pallidoluysian Atrophy,Glycogen Storage Disease Iv,Ovary Transitional Cell Carcinoma,Neonatal Period Electroclinical Syndrome,Epilepsy, Myoclonic Juvenile,Myoclonic Epilepsy Of Lafora,Myoclonic Epilepsy Of Unverricht And Lundborg |
4r30_c | O95278 | ENSG00000112425 | EPM2A | 98.00 | 1.80E-09 | 1.90E-13 | 91.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | Ci-VSP |
Ci-VSP |
Ciona intestinalis | 3v0d_a | Q4W8A1 | 99.40 | 8.20E-18 | 8.00E-22 | 162.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL128W | TEP1 | SGDID:S000005072 | DSP1 PTP135 At1g05000 T7A14.14 |
Tyrosine-protein phosphatase DSP1 (EC 3.1.3.48) (Protein PLANT AND FUNGI ATYPICAL DUAL-SPECIFICITY PHOSPHATASE 1) (AtPFA-DSP1) (Tyrosine-protein phosphatase At1g05000) |
3.1.3.48 | Arabidopsis thaliana | 1xri_b | Q9ZVN4 | 98.20 | 4.80E-10 | 5.00E-14 | 92.40 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | YVH1 YIR026C |
Tyrosine-protein phosphatase YVH1 (PTPase YVH1) (EC 3.1.3.48) |
3.1.3.48 | Saccharomyces cerevisiae | 6rzz_s | Q02256 | 98.30 | 2.30E-10 | 2.10E-14 | 112.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | STYX |
Serine/threonine/tyrosine-interacting protein (Inactive tyrosine-protein phosphatase STYX) (Phosphoserine/threonine/tyrosine interaction protein) |
Homo sapiens | Type 1 Diabetes Mellitus |
2r0b_a | Q8WUJ0 | ENSG00000198252 | STYX | 98.00 | 2.10E-09 | 2.30E-13 | 87.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL128W | TEP1 | SGDID:S000005072 | DUSP11 PIR1 |
RNA/RNP complex-1-interacting phosphatase (EC 3.1.3.-) (Dual specificity protein phosphatase 11) (Phosphatase that interacts with RNA/RNP complex 1) |
3.1.3.- | Homo sapiens | Keratosis Follicularis Spinulosa Decalvans,Amyotrophic Lateral Sclerosis 1,Cardiomyopathy, Familial Hypertrophic, 4,Keratosis Pilaris Atrophicans,Amyotrophic Lateral Sclerosis 3,Amyotrophic Lateral Sclerosis Type 14,Cardiomyopathy, Familial Hypertrophic, 6 |
4jmj_a | O75319 | ENSG00000144048 | DUSP11 | 98.10 | 8.90E-10 | 9.30E-14 | 93.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | DUSP28 |
Dual specificity phosphatase 28 (EC 3.1.3.16) (EC 3.1.3.48) |
3.1.3.16,3.1.3.48, | Homo sapiens | 5y15_a | Q4G0W2 | ENSG00000188542 | DUSP28 | 98.00 | 2.80E-09 | 2.80E-13 | 93.10 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL128W | TEP1 | SGDID:S000005072 | DUSP13 DUSP13B TMDP |
Dual specificity protein phosphatase 13 isoform B (DUSP13B) (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase SKRP4) (Testis- and skeletal-muscle-specific DSP) |
3.1.3.16,3.1.3.48, | Homo sapiens | Cowden Syndrome,Cardiomyopathy, Dilated, 1a,Juvenile Polyposis Syndrome,Ring Dermoid Of Cornea,Ruvalcaba Syndrome,Emery-Dreifuss Muscular Dystrophy 2, Autosomal Dominant,Myoclonic Epilepsy Of Lafora |
2gwo_c | Q9UII6 | ENSG00000079393 | DUSP13 | 98.00 | 2.70E-09 | 2.70E-13 | 92.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | PTEN MMAC1 TEP1 |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog) |
3.1.3.16,3.1.3.48,3.1.3.67 | Homo sapiens | Breast Duct Papilloma,Skin Melanoma,Gliomatosis Cerebri,Heart Disease,Uterine Body Mixed Cancer,Uterine Carcinosarcoma,Endometrial Cancer,Peritoneum Cancer,Follicular Adenoma,Squamous Cell Carcinoma,Childhood T-Cell Acute Lymphoblastic Leukemia,Retinitis Pigmentosa,Thyroid Gland Cancer,Myopathy,Penile Cancer,Neuroendocrine Carcinoma,Acral Lentiginous Melanoma,Adenoid Cystic Carcinoma,Seizure Disorder,Vacterl With Hydrocephalus,Carcinosarcoma,Chordoma,Cowden Syndrome,Large Intestine Lipoma,Suppression Of Tumorigenicity 12,Melanoma,Endometrial Hyperplasia,Ocular Hypertension,Gastroesophageal Adenocarcinoma,Thyroid Gland Anaplastic Carcinoma,Diabetes Mellitus,Dedifferentiated Liposarcoma,Cowden Syndrome 1,Non-Alcoholic Steatohepatitis,Cortical Blindness,Fallopian Tube Carcinoma,Bilateral Breast Cancer,Synchronous Bilateral Breast Carcinoma,Peripheral Nervous System Neoplasm,Uterine Corpus Cancer,Connective Tissue Cancer,Dysgerminoma,Clear Cell Renal Cell Carcinoma,Alzheimer Disease,Sarcomatoid Renal Cell Carcinoma,Primary Cutaneous B-Cell Lymphoma,Vulvar Disease,Rasopathy,Vulvar Seborrheic Keratosis,Gemistocytic Astrocytoma,Glottis Squamous Cell Carcinoma,Neurofibroma,Bile Duct Cancer,Intestinal Benign Neoplasm,Malignant Ovarian Surface Epithelial-Stromal Neoplasm,Ovary Epithelial Cancer,Retinal Cancer,Congenital Lipomatous Overgrowth, Vascular Malformations, And Epidermal Nevi,Focal Epilepsy,Glial Tumor,Infratentorial Cancer,Cerebral Visual Impairment,Neurofibromatosis, Type I,Colon Adenocarcinoma,Ganglioneuroma,Segmental Outgrowth-Lipomatosis-Arteriovenous Malformation-Epidermal Nevus Syndrome,Vulva Cancer,Adenosquamous Carcinoma,Arteriosclerosis,Neuroblastoma,Subependymal Glioma,Benign Ependymoma,Pilocytic Astrocytoma,Proteus-Like Syndrome,Gangliocytoma,Serrated Polyposis Syndrome,Nevus, Epidermal,Inherited Cancer-Predisposing Syndrome,Mixed Oligodendroglioma-Astrocytoma,Glioma,Leukemia, Acute Myeloid,Sporadic Breast Cancer,Hereditary Mixed Polyposis Syndrome,Basal Cell Carcinoma,Thyroid Hurthle Cell Adenoma,Glioma Susceptibility 2,Hemangioma,Hemimegalencephaly,Leukemia, Acute Lymphoblastic,High-Grade Astrocytoma,Mixed Glioma,Papilloma,Autonomic Nervous System Neoplasm,Kidney Cancer,Cystadenoma,Basal Cell Nevus Syndrome,Cystic Teratoma,Transitional Cell Carcinoma,Thyroid Carcinoma,Genetic Obesity,Juvenile Polyposis Of Infancy,Bladder Cancer,Thyroid Tumor,Thymus Gland Disease,Mn1 C-Terminal Truncation Syndrome,Brain Cancer,Precursor T-Cell Acute Lymphoblastic Leukemia,Skin Lipoma,Breast Lipoma,Pulmonary Neuroendocrine Tumor,Lung Oat Cell Carcinoma,Endometrial Adenocarcinoma,Laryngeal Squamous Cell Carcinoma,Endometriosis,Papillary Adenofibroma,Chronic Leukemia,Osteoporosis,Ovarian Cancer,Adenocarcinoma,Tuberous Sclerosis 2,In Situ Carcinoma,Tuberous Sclerosis,Testicular Cancer,T-Cell Acute Lymphoblastic Leukemia,Leukodystrophy,Female Reproductive Endometrioid Cancer,Acute Megakaryocytic Leukemia,Breast Cancer,Glioblastoma,Squamous Cell Carcinoma, Head And Neck,Hereditary Breast Ovarian Cancer Syndrome,Malignant Astrocytoma,High Grade Glioma,Gliosarcoma,Giant Cell Glioblastoma,Adult Astrocytic Tumour,Anaplastic Astrocytoma,Parkinson Disease, Late-Onset,Colorectal Cancer,Lipoma Of Colon,Peripheral Nervous System Disease,Endometrial Serous Adenocarcinoma,Histiocytic Sarcoma,Serous Cystadenocarcinoma,Hepatocellular Carcinoma,Premature Menopause,Endometrioid Ovary Carcinoma,Vacterl Association With Hydrocephalus,Lipomatosis,Skin Papilloma,Ovarian Clear Cell Adenofibroma,Oligodendroglioma,Microcephaly,Hydrocephalus,Hydromyelia,Rhabdomyosarcoma,Cerebral Cavernous Malformations,Tongue Disease,Thymus Cancer,Ovarian Disease,Teratoma,Estrogen Excess,Juvenile Polyposis Syndrome,Immunodeficiency 14,Peutz-Jeghers Syndrome,Fanconi Anemia, Complementation Group A,Liposarcoma,Vacterl Association,Skin Carcinoma,Gastric Cancer,Arteriovenous Malformation,West Syndrome,Prostate Cancer,Disease Of Mental Health,Pancreatic Ductal Adenocarcinoma,Proteus Syndrome,Cervical Cancer,Ovarian Cystadenocarcinoma,Penile Disease,Mixed Cell Type Cancer,Testicular Microlithiasis,Contractures, Pterygia, And Spondylocarpotarsal Fusion Syndrome 1a,Central Nervous System Cancer,Thrombocytopenia,Cervical Adenocarcinoma,Ovary Adenocarcinoma,Mucinous Stomach Adenocarcinoma,Gastric Adenocarcinoma,Type 2 Diabetes Mellitus,Verrucous Carcinoma,Ruvalcaba Syndrome,Lynch Syndrome,Lung Squamous Cell Carcinoma,Fragile X Syndrome,Thyroid Gland Follicular Carcinoma,Bladder Urothelial Carcinoma,Renal Cell Carcinoma, Papillary, 1,Small Cell Cancer Of The Lung,Macrocephaly/Autism Syndrome,Esophageal Cancer,Birt-Hogg-Dube Syndrome,Respiratory System Benign Neoplasm,Reproductive Organ Benign Neoplasm,Myelodysplastic Syndrome,Gastric Cancer, Hereditary Diffuse,Small Cell Carcinoma,Thyroid Cancer, Nonmedullary, 2,Tumor Predisposition Syndrome,Autosomal Genetic Disease,Diffuse Large B-Cell Lymphoma,Mantle Cell Lymphoma,Peripheral T-Cell Lymphoma,Tuberous Sclerosis 1,Hashimoto Thyroiditis,Gastrointestinal Stromal Tumor,Colorectal Adenoma,Colorectal Adenocarcinoma,Tongue Squamous Cell Carcinoma,Acute Promyelocytic Leukemia,Cutaneous Telangiectasia And Cancer Syndrome, Familial,Renal Cell Carcinoma, Nonpapillary,Large Intestine Adenocarcinoma,Ovarian Clear Cell Carcinoma,Uterine Corpus Endometrial Carcinoma,Nasopharyngeal Carcinoma,Meningioma, Familial,Pervasive Developmental Disorder,Autism Spectrum Disorder,Pre-Malignant Neoplasm,Ductal Carcinoma In Situ,Cell Type Benign Neoplasm,Central Nervous System Benign Neoplasm,Cardiovascular Organ Benign Neoplasm,Uterine Benign Neoplasm,Nijmegen Breakage Syndrome,Keloid Formation,Leukemia, Chronic Lymphocytic,Juvenile Myelomonocytic Leukemia,Li-Fraumeni Syndrome,Lipomatosis, Multiple,Systemic Lupus Erythematosus,Macroglossia,Chromosome 10q23 Deletion Syndrome,Left Ventricular Noncompaction,Myeloma, Multiple,Medulloblastoma,Spinal Disease,Autism,Melanoma, Cutaneous Malignant 1,Melanoma, Uveal,Early-Onset Parkinson'S Disease,Retinitis Pigmentosa 11,Lung Cancer,Palmoplantar Keratoderma, Bothnian Type,Pancreatic Cancer |
1d5r_a | P60484 | ENSG00000171862 | PTEN | 99.50 | 3.50E-18 | 3.40E-22 | 163.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | Dusp28 |
Dual specificity phosphatase 28 (EC 3.1.3.16) (EC 3.1.3.48) |
3.1.3.16,3.1.3.48, | Mus musculus | 2hcm_a | Q8BTR5 | 98.20 | 2.60E-10 | 2.80E-14 | 93.70 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | CDC14B |
Dual specificity protein phosphatase CDC14B (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog B) |
3.1.3.16,3.1.3.48, | Homo sapiens | Adrenal Gland Pheochromocytoma |
1ohc_a | O60729 | ENSG00000081377 | CDC14B | 98.50 | 3.40E-11 | 3.20E-15 | 117.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | DUSP7 PYST2 |
Dual specificity protein phosphatase 7 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST2) |
3.1.3.16,3.1.3.48, | Homo sapiens | Pulmonary Systemic Sclerosis,Variola Major |
4y2e_b | Q16829 | ENSG00000164086 | DUSP7 | 98.10 | 1.10E-09 | 1.20E-13 | 88.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | DUSP15 C20orf57 VHY |
Dual specificity protein phosphatase 15 (EC 3.1.3.16) (EC 3.1.3.48) (VH1-related member Y) (Vaccinia virus VH1-related dual-specific protein phosphatase Y) |
3.1.3.16,3.1.3.48, | Homo sapiens | Nanophthalmos |
1yz4_a | Q9H1R2 | ENSG00000149599 | DUSP15 | 98.20 | 5.10E-10 | 5.40E-14 | 91.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | SDP1 YIL113W |
Dual-specificity protein phosphatase SDP1 (EC 3.1.3.48) (Stress-inducible MAPK phosphatase) |
3.1.3.48 | Saccharomyces cerevisiae | 2j16_a | P40479 | 98.20 | 3.60E-10 | 3.70E-14 | 96.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | 01orf_00051 |
01orf_00051 |
3.1.3.- | Orf virus | 5ncr_a | Q6TW43 | 98.00 | 1.50E-09 | 1.60E-13 | 93.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | CTHT_0021070 |
CTHT_0021070 |
3.1.3.48 | Chaetomium thermophilum | 5m43_a | G0S3H6 | 98.00 | 1.50E-09 | 1.40E-13 | 98.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL128W | TEP1 | SGDID:S000005072 | CDKN3 CDI1 CIP2 KAP |
Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Cyclin-dependent kinase interactor 1) (Cyclin-dependent kinase-interacting protein 2) (Kinase-associated phosphatase) |
3.1.3.16,3.1.3.48, | Homo sapiens | Endometrial Cancer,Bladder Lateral Wall Cancer,Cowden Syndrome,Endometrial Hyperplasia,Ovary Sarcoma,Retinal Cancer,Epicardium Cancer,Mandibular Cancer,Cystic Fibrosis,Colon Sarcoma,Cervix Carcinoma,Ovarian Cancer,Breast Cancer,Glioblastoma,Colorectal Cancer,Hepatocellular Carcinoma,Cerebral Cavernous Malformations,Centronuclear Myopathy,Prostate Cancer,Type 2 Diabetes Mellitus,Fragile X Syndrome,Lymphoma, Non-Hodgkin, Familial,Beckwith-Wiedemann Syndrome,Fanconi Renotubular Syndrome 1,Brugada Syndrome 4,Acute Promyelocytic Leukemia,Juvenile Myelomonocytic Leukemia,Ataxia-Telangiectasia,Melanoma, Cutaneous Malignant 1 |
1fpz_e | Q16667 | ENSG00000100526 | CDKN3 | 98.20 | 2.70E-10 | 2.70E-14 | 99.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL128W | TEP1 | SGDID:S000005072 | DUSP23 LDP3 VHZ |
Dual specificity protein phosphatase 23 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular mass dual specificity phosphatase 3) (LDP-3) (VH1-like phosphatase Z) |
3.1.3.16,3.1.3.48, | Homo sapiens | 4erc_b | Q9BVJ7 | ENSG00000158716 | DUSP23 | 98.40 | 4.90E-11 | 5.20E-15 | 97.50 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL128W | TEP1 | SGDID:S000005072 | RPL39 RPL46 SPB2 YJL189W J0360 |
60S ribosomal protein L39 (L46) (Large ribosomal subunit protein eL39) (YL40) |
Saccharomyces cerevisiae | 6n8o_y | P04650 | 98.30 | 2.30E-10 | 2.10E-14 | 112.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL128W | TEP1 | SGDID:S000005072 | Ptpmt1 Plip |
Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (Phosphoinositide lipid phosphatase) (Protein-tyrosine phosphatase mitochondrial 1) (EC 3.1.3.16) (EC 3.1.3.48) |
3.1.3.16,3.1.3.27,3.1.3.48 | Mus musculus | 3rgo_a | Q66GT5 | 98.20 | 2.80E-10 | 2.90E-14 | 93.30 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |